Tumour-specific and organ-specific protein synthesis rates in patients with pancreatic cancer

Journal article


van Dijk, David P.J., Horstman, Astrid M. H., Smeets, Joey S. J., den Dulk, Marcel, Grabsch, Heike I., Dejong, Cornelis H. C., Rensen, Sander S., Olde Damink, Steven W. M. and van Loon, Luc J. C.. (2019). Tumour-specific and organ-specific protein synthesis rates in patients with pancreatic cancer. Journal of Cachexia, Sarcopenia and Muscle. 10(3), pp. 549 - 556. https://doi.org/10.1002/jcsm.12419
Authorsvan Dijk, David P.J., Horstman, Astrid M. H., Smeets, Joey S. J., den Dulk, Marcel, Grabsch, Heike I., Dejong, Cornelis H. C., Rensen, Sander S., Olde Damink, Steven W. M. and van Loon, Luc J. C.
Abstract

Background: Living tissues maintain a fine balance between protein synthesis and protein breakdown rates. Animal studies indicate that protein synthesis rates are higher in organs when compared with skeletal muscle tissue. As such, organ and tumour protein synthesis could have major effects on whole‐body protein metabolism in wasting disorders such as cancer cachexia. We aimed to assess protein synthesis rates in pancreatic tumour tissue and healthy pancreas, liver, and skeletal muscle tissue in vivo in humans. Methods: In eight patients with pancreatic cancer undergoing pancreaticoduodenectomy, primed continuous infusions with L‐[ring‐13C6]phenylalanine and L‐[3,5‐2H2]tyrosine were started prior to surgery and continued throughout the surgical procedures. During surgery, plasma samples and biopsies from the pancreas, pancreatic tumour, liver, and vastus lateralis muscle were taken. Post‐absorptive fractional protein synthesis rates were determined by measuring incorporation of labelled L‐[ring‐13C6]phenylalanine in tissue protein using the weighed plasma L‐[ring‐13C6]phenylalanine enrichments as the precursor pool. Results: Five male patients and three female patients with a mean age of 67 ± 2 years were included into this study. Plasma L‐[ring‐13C6]phenylalanine enrichments (6–9 mole per cent excess) did not change during surgery (P = 0.60). Pancreatic tumour protein synthesis rates were 2.6‐fold lower than surrounding pancreatic tissue protein synthesis rates (0.268 ± 0.053 vs. 0.694 ± 0.228%/h, respectively; P = 0.028) and 1.7‐fold lower than liver protein synthesis rates (0.268 ± 0.053 vs. 0.448 ± 0.043%/h, respectively; P = 0.046). Among healthy organ samples, protein synthesis rates were 20‐fold and 13‐fold higher in pancreas and liver, respectively, compared with skeletal muscle tissue (0.694 ± 0.228 and 0.448 ± 0.043 vs. 0.035 ± 0.005%/h, respectively; P < 0.05). Conclusions: Liver and pancreas tissue protein synthesis rates are higher when compared with pancreatic tumour and skeletal muscle tissue protein synthesis rates and can, therefore, strongly impact whole‐body protein metabolism in vivo in humans.

Keywordsprotein metabolism; pancreatic cancer; pancreas; liver
Year2019
JournalJournal of Cachexia, Sarcopenia and Muscle
Journal citation10 (3), pp. 549 - 556
PublisherWiley - V C H Verlag GmbH & Co. KGaA
ISSN2190-5991
Digital Object Identifier (DOI)https://doi.org/10.1002/jcsm.12419
Scopus EID2-s2.0-85062947349
Open accessOpen access
Page range549 - 556
Research GroupMary MacKillop Institute for Health Research
Publisher's version
License
Place of publicationGermany
Permalink -

https://acuresearchbank.acu.edu.au/item/89vq1/tumour-specific-and-organ-specific-protein-synthesis-rates-in-patients-with-pancreatic-cancer

Download files


Publisher's version
  • 47
    total views
  • 59
    total downloads
  • 4
    views this month
  • 2
    downloads this month
These values are for the period from 19th October 2020, when this repository was created.

Export as